CN Patent

CN112618700A — 促胰岛素肽的稳定制剂

Assigned to Novo Nordisk AS · Expires 2021-04-09 · 5y expired

What this patent protects

本发明涉及包含促胰岛素肽的稳定的药物组合物及其制备方法、制备GLP‑1化合物稳定溶液的方法、以及通过该方法可获得的GLP‑1化合物的储存‑稳定的药物组合物。

USPTO Abstract

本发明涉及包含促胰岛素肽的稳定的药物组合物及其制备方法、制备GLP‑1化合物稳定溶液的方法、以及通过该方法可获得的GLP‑1化合物的储存‑稳定的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112618700A
Jurisdiction
CN
Classification
—
Expires
2021-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.